OAB Treatment Market, Global Outlook and Forecast 2023-2030
This repor mainly studies OAB (overactive bladder) treatment market. Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control).
This report aims to provide a comprehensive presentation of the global market for OAB Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OAB Treatment. This report contains market size and forecasts of OAB Treatment in global, including the following market information:
Global OAB Treatment Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global OAB Treatment market was valued at US$ 3963.6 million in 2022 and is projected to reach US$ 4379.5 million by 2029, at a CAGR of 1.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
AbbVie is the largest producer of OAB treatment worldwide, holding over 40% of the overall market share. North America is currently the largest consumption market in the world, with over 50% of the market, followed by Europe and Japan.
We surveyed the OAB Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global OAB Treatment Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global OAB Treatment Market Segment Percentages, by Type, 2022 (%)
Anticholinergics
Mirabegron
Botox
Global OAB Treatment Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global OAB Treatment Market Segment Percentages, by Application, 2022 (%)
Idiopathic Overactive Bladder
Neurogenic Overactive Bladder
Global OAB Treatment Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global OAB Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies OAB Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies OAB Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Astellas Pharma
Allergan
Pfizer
Teva (Activas)
Johnson & Johnson
Outline of Major Chapters:
Chapter 1: Introduces the definition of OAB Treatment, market overview.
Chapter 2: Global OAB Treatment market size in revenue.
Chapter 3: Detailed analysis of OAB Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of OAB Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
